Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PaciFIST-1: Paclitaxel for AV Fistula Stenosis
NCT01868984Phase 2Terminated
- Sponsor
- Englewood Hospital
- Start
- May 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of paclitaxel in arteriovenous fistula stenosis (2 arms), sponsored by Englewood Hospital. Primary endpoints: Target Lesion Revascularization at 6 months and Target Segment Revascularization at 6 months. Started May 2013; status: terminated.
02
Drugs
paclitaxel
03
Conditions
arteriovenous fistula stenosis
Beyond the preview
Go deeper on NCT01868984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01868984.